← FDA Drug Approvals (Drugs@FDA)

INCRELEX

BLA · Biologics License Application · Sponsor: IPSEN INC · Approved 2005-08-30

Drug application

FDA Application #

BLA021839

Application type

Biologics License Application

Brand name

INCRELEX

Generic name

MECASERMIN

Active ingredients

MECASERMIN RECOMBINANT

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

IPSEN INC

Manufacturer

Ipsen Biopharmaceuticals, Inc.

First approval

2005-08-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown